olprinone has been researched along with colforsin daropate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamamoto, H | 1 |
| Hattori, Y; Oishi, H; Takano, K; Takebe, M; Tomita, K; Yamazaki, M; Yokoo, H | 1 |
2 other study(ies) available for olprinone and colforsin daropate
| Article | Year |
|---|---|
[The effect of PDEIII inhibitors and colforsin daropate on hypoxic pulmonary vasoconstriction in rabbit lungs].
Topics: Animals; Colforsin; Hypoxia; Imidazoles; In Vitro Techniques; Male; Milrinone; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyridones; Rabbits; Vasoconstriction | 2008 |
Olprinone and colforsin daropate alleviate septic lung inflammation and apoptosis through CREB-independent activation of the Akt pathway.
Topics: Acute Lung Injury; Androstadienes; Animals; Apoptosis; Cecum; Colforsin; Cyclic AMP Response Element-Binding Protein; Cytokines; Enzyme Activation; Enzyme Activators; Hypotension; Imidazoles; Ligation; Lung; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Pneumonia; Proto-Oncogene Proteins c-akt; Pyridones; Shock, Septic; Signal Transduction; Wortmannin | 2012 |